Mrv0541 06111412442D 19 20 0 0 0 0 999 V2000 -0.7144 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7144 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 -4.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 -3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -3.7125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7144 1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7144 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5723 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 -2.4750 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 2.8578 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3 1 1 0 0 0 0 5 4 1 0 0 0 0 6 4 1 0 0 0 0 9 7 1 0 0 0 0 10 8 2 0 0 0 0 11 5 1 0 0 0 0 12 6 1 0 0 0 0 14 2 1 0 0 0 0 14 13 1 0 0 0 0 15 3 1 0 0 0 0 15 7 2 0 0 0 0 15 8 1 0 0 0 0 16 9 2 0 0 0 0 16 10 1 0 0 0 0 17 14 1 0 0 0 0 17 16 1 0 0 0 0 18 11 1 0 0 0 0 18 12 1 0 0 0 0 18 13 1 0 0 0 0 19 17 2 0 0 0 0 M END > DB08992 > drugbank > CCC1=CC=C(C=C1)C(=O)C(C)CN1CCCCC1 > InChI=1S/C17H25NO/c1-3-15-7-9-16(10-8-15)17(19)14(2)13-18-11-5-4-6-12-18/h7-10,14H,3-6,11-13H2,1-2H3 > SQUNAWUMZGQQJD-UHFFFAOYSA-N > C17H25NO > 259.3865 > 259.193614427 > 2 > 44 > 0.9834161028741999 > 31.738177721946215 > 1 > 0 > 0 > 1 > 1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one > 4.27 > 4.010747023666666 > -3.62 > 0 > 1 > 2 > 1 > 16.504831156678982 > 8.773050707221035 > 20.310000000000002 > 80.94789999999998 > 5 > 1 > 6.17e-02 g/l > tetrahydrofolic acid > 1 > DB08992 > investigational > Eperisone > (2RS)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one; Eperison; Eperisona; Epérisone; Eperisone; Eperisonum > Akitonal; Elexin; Myonal; Myoperison; Rapisone > Eperisone hydrochloride $$$$